Li-Sheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li-Sheng Zhang has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Wei Ju
Department of Chemistry, The University of Chicago, Chicago, USA
23 shared publications - Jiangbo Wei
Department of Chemistry, The University of Chicago, Chicago, USA
23 shared publications - Yiyi Ji
Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
18 shared publications - Han Li
The University of Chicago 2 Department of Chemistry Chicago, Illinois
17 shared publications - Peng Xia
Department of Chemistry, The University of Chicago, Chicago, IL 60637, USA
17 shared publications - Ruitu Lyu
Department of Chemistry, The University of Chicago, Chicago, USA
17 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in Nature Chemical Biology
- p. 1-14
PUS7 pseudouridylation of 7SK orchestrates human somatic cell reprogramming into iPS cells
Reprogramming human somatic cells into induced pluripotent stem cells (iPS cells) provides huge potential for regenerative medicine but its molecular regulation remains incompletely understood. In this study, we identify PUS7 as an RNA modification checkpoint that promotes acquisition of pluripotency. PUS7 loss markedly impairs reprogramming, whereas its overexpression accelerates reprogramming efficiency and kinetics. Mechanistically, PUS7 pseudouridylates U250 of the chromatin-associated noncoding RNA 7SK, enhancing its interaction with the BRG/BRM-associated factor (BAF) complex. Loss of this modification disrupts 7SK–BAF association, reduces BAF chromatin occupancy and decreases global chromatin accessibility. We further establish PSKM (PUS7, SOX2, KLF4, MYC) reprogramming, which generates iPS cells with faithful imprinting, robust lineage potential and improved developmental fidelity. PSKM-iPS cells differentiate efficiently toward neural and hematopoietic lineages and undergo gastrulation-like morphogenesis. These findings link 7SK pseudouridylation to chromatin remodeling and establish PSKM as a framework for generating high-quality human iPS cells for modeling and regenerative medicine.
- 12 October 2026
- Published by Springer Nature in Nature Chemical Biology
- p. 1-14
Open AccessPUS7 pseudouridylation of 7SK orchestrates human somatic cell reprogramming into iPS cells
Reprogramming human somatic cells into induced pluripotent stem cells (iPS cells) provides huge potential for regenerative medicine but its molecular regulation remains incompletely understood. In this study, we identify PUS7 as an RNA modification checkpoint that promotes acquisition of pluripotency. PUS7 loss markedly impairs reprogramming, whereas its overexpression accelerates reprogramming efficiency and kinetics. Mechanistically, PUS7 pseudouridylates U250 of the chromatin-associated noncoding RNA 7SK, enhancing its interaction with the BRG/BRM-associated factor (BAF) complex. Loss of this modification disrupts 7SK–BAF association, reduces BAF chromatin occupancy and decreases global chromatin accessibility. We further establish PSKM (PUS7, SOX2, KLF4, MYC) reprogramming, which generates iPS cells with faithful imprinting, robust lineage potential and improved developmental fidelity. PSKM-iPS cells differentiate efficiently toward neural and hematopoietic lineages and undergo gastrulation-like morphogenesis. These findings link 7SK pseudouridylation to chromatin remodeling and establish PSKM as a framework for generating high-quality human iPS cells for modeling and regenerative medicine.
- Open Access
- 6 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1522-1533
Multi-omics and developmental comparison of direct and conventional warming methods in vitrified human and mouse cleavage-stage embryos
STUDY QUESTION: Does direct warming preserve embryonic developmental competence and molecular integrity as well as conventional multi-step warming in vitrified human and mouse cleavage-stage embryos? SUMMARY ANSWER: Direct warming yielded comparable developmental and molecular outcomes to conventional warming in both mouse and human cleavage-stage embryos. WHAT IS KNOWN ALREADY: Conventional embryo warming uses stepwise cryoprotectant dilution to minimize toxicity and osmotic shock. Direct warming methods have been proposed, but their impact on post-warming development and the molecular comparison remains unclear. STUDY DESIGN, SIZE, DURATION: This is a controlled experimental study conducted over 18 months. A total of 490 vitrified mouse embryos and 15 donated human embryos were tested either in direct or conventional warming group. A subset underwent embryo transfer and follow-up. Parallel transcriptomic and DNA methylation profiling was performed on mouse and donated human embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mouse cleavage-stage embryos (C57BL/6J) were vitrified and randomly assigned to direct (n = 265) or conventional (n = 225) warming. Post-warming survival and blastocyst formation were assessed in vitro. A subset (n = 211) underwent embryo transfer to evaluate implantation, live birth, and postnatal development to Day 21. For molecular analysis, pooled mouse embryos from fresh, conventional, and direct groups were analyzed by bulk RNA-seq and bisulfite sequencing. Ten vitrified human embryos (n = 5 per group) were analyzed individually by scRNA-seq and scBS-seq. All procedures were conducted under standard IVF lab conditions with ethical approval. MAIN RESULTS AND THE ROLE OF CHANCE: Direct warming in mouse achieved comparable survival (95.8% vs 93.8%), blastocyst formation (88.6% vs 88.2%), implantation (82.5% vs 83.0%), and live birth rates (69.6% vs 71.1%) to conventional warming (all P > 0.05). Offspring showed similar growth, developmental milestones, and organ histology. Mouse transcriptome and methylome profiles revealed minimal differences and no significant pathway enrichment. In human embryos, ion channel-related gene variability was observed but without coordinated pathway disruption. Global methylation levels remained within expected developmental ranges. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: While the mouse model enables in vivo validation, species-specific differences in embryo size, membrane properties, and development may limit generalizability. As all embryos were cultured under optimized conditions, caution is advised when extrapolating to diverse clinical settings. WIDER IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study to provide multi-level evidence supporting the safety and efficacy of direct warming as an alternative to conventional multi-step embryo warming protocols. By incorporating in vivo reproductive outcomes, postnatal development, and molecular profiling, it strengthens current evidence on the feasibility of this approach. The absence of pathway-level disruptions in transcriptome and methylome datasets suggests that direct warming does not impair essential developmental programs. These findings may support the clinical use of simplified warming procedures, especially for cleavage-stage embryo transfer or in resource-limited settings. However, further clinical studies are warranted to confirm long-term safety in humans. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Collaborative Research Fund (CRF-C4007-24E), and Early Career Scheme (ECS-26103623) from the University Grants Committee (UGC), and Health and Medical Research Fund (HMRF 12230736) from the Hong Kong Government. The authors report no competing interests. TRIAL REGISTRATION NUMBER: N/A.
- 6 July 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1522-1533
Open AccessMulti-omics and developmental comparison of direct and conventional warming methods in vitrified human and mouse cleavage-stage embryos
STUDY QUESTION: Does direct warming preserve embryonic developmental competence and molecular integrity as well as conventional multi-step warming in vitrified human and mouse cleavage-stage embryos? SUMMARY ANSWER: Direct warming yielded comparable developmental and molecular outcomes to conventional warming in both mouse and human cleavage-stage embryos. WHAT IS KNOWN ALREADY: Conventional embryo warming uses stepwise cryoprotectant dilution to minimize toxicity and osmotic shock. Direct warming methods have been proposed, but their impact on post-warming development and the molecular comparison remains unclear. STUDY DESIGN, SIZE, DURATION: This is a controlled experimental study conducted over 18 months. A total of 490 vitrified mouse embryos and 15 donated human embryos were tested either in direct or conventional warming group. A subset underwent embryo transfer and follow-up. Parallel transcriptomic and DNA methylation profiling was performed on mouse and donated human embryos. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mouse cleavage-stage embryos (C57BL/6J) were vitrified and randomly assigned to direct (n = 265) or conventional (n = 225) warming. Post-warming survival and blastocyst formation were assessed in vitro. A subset (n = 211) underwent embryo transfer to evaluate implantation, live birth, and postnatal development to Day 21. For molecular analysis, pooled mouse embryos from fresh, conventional, and direct groups were analyzed by bulk RNA-seq and bisulfite sequencing. Ten vitrified human embryos (n = 5 per group) were analyzed individually by scRNA-seq and scBS-seq. All procedures were conducted under standard IVF lab conditions with ethical approval. MAIN RESULTS AND THE ROLE OF CHANCE: Direct warming in mouse achieved comparable survival (95.8% vs 93.8%), blastocyst formation (88.6% vs 88.2%), implantation (82.5% vs 83.0%), and live birth rates (69.6% vs 71.1%) to conventional warming (all P > 0.05). Offspring showed similar growth, developmental milestones, and organ histology. Mouse transcriptome and methylome profiles revealed minimal differences and no significant pathway enrichment. In human embryos, ion channel-related gene variability was observed but without coordinated pathway disruption. Global methylation levels remained within expected developmental ranges. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: While the mouse model enables in vivo validation, species-specific differences in embryo size, membrane properties, and development may limit generalizability. As all embryos were cultured under optimized conditions, caution is advised when extrapolating to diverse clinical settings. WIDER IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study to provide multi-level evidence supporting the safety and efficacy of direct warming as an alternative to conventional multi-step embryo warming protocols. By incorporating in vivo reproductive outcomes, postnatal development, and molecular profiling, it strengthens current evidence on the feasibility of this approach. The absence of pathway-level disruptions in transcriptome and methylome datasets suggests that direct warming does not impair essential developmental programs. These findings may support the clinical use of simplified warming procedures, especially for cleavage-stage embryo transfer or in resource-limited settings. However, further clinical studies are warranted to confirm long-term safety in humans. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Collaborative Research Fund (CRF-C4007-24E), and Early Career Scheme (ECS-26103623) from the University Grants Committee (UGC), and Health and Medical Research Fund (HMRF 12230736) from the Hong Kong Government. The authors report no competing interests. TRIAL REGISTRATION NUMBER: N/A.
- Open Access
- 4 June 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Quantitative RNA pseudouridine landscape reveals dynamic modification patterns and evolutionary conservation across bacterial species
Pseudouridine (Ψ) modifications are the most abundant RNA modifications; however, their distribution and functional significance in bacteria remain largely unexplored compared to eukaryotic systems. In this study, we present the first transcriptome-wide and quantitative mapping of Ψ modifications across five diverse bacterial species ( Bacillus cereus , Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Pseudomonas syringae ) at single-base resolution, utilizing the optimized baBID-seq method for bacterial RNA. Our analysis revealed growth phase-dependent dynamics of pseudouridylation in bacterial tRNA and mRNA, particularly in genes enriched in core metabolic pathways. Comparative analysis demonstrated evolutionarily conserved features of Ψ modifications, such as dominant motif contexts, Ψ clustering within operons, etc. Functional analysis indicated Ψ modifications affect bacterial mRNA stability, translation, and interactions with specific RNA-binding proteins in response to changing cellular demands during growth phase transitions. The integrated computational analysis on local RNA architecture was conducted to elucidate the structure-dependent Ψ modifications in bacterial RNA. Furthermore, we developed an integrated deep learning framework, combining LSTM-transformer-GNN-based neural networks (pseU_NN) to capture both RNA sequence and local structure features for effective prediction of Ψ-modified sites. Overall, our study provides valuable insights into the landscapes of bacterial RNA Ψ modifications and establishes a foundation for future mechanistic investigations on bacterial Ψ functions.
- 4 June 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessQuantitative RNA pseudouridine landscape reveals dynamic modification patterns and evolutionary conservation across bacterial species
Pseudouridine (Ψ) modifications are the most abundant RNA modifications; however, their distribution and functional significance in bacteria remain largely unexplored compared to eukaryotic systems. In this study, we present the first transcriptome-wide and quantitative mapping of Ψ modifications across five diverse bacterial species ( Bacillus cereus , Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Pseudomonas syringae ) at single-base resolution, utilizing the optimized baBID-seq method for bacterial RNA. Our analysis revealed growth phase-dependent dynamics of pseudouridylation in bacterial tRNA and mRNA, particularly in genes enriched in core metabolic pathways. Comparative analysis demonstrated evolutionarily conserved features of Ψ modifications, such as dominant motif contexts, Ψ clustering within operons, etc. Functional analysis indicated Ψ modifications affect bacterial mRNA stability, translation, and interactions with specific RNA-binding proteins in response to changing cellular demands during growth phase transitions. The integrated computational analysis on local RNA architecture was conducted to elucidate the structure-dependent Ψ modifications in bacterial RNA. Furthermore, we developed an integrated deep learning framework, combining LSTM-transformer-GNN-based neural networks (pseU_NN) to capture both RNA sequence and local structure features for effective prediction of Ψ-modified sites. Overall, our study provides valuable insights into the landscapes of bacterial RNA Ψ modifications and establishes a foundation for future mechanistic investigations on bacterial Ψ functions.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic and functional effects of DDC and SLC6A4 overexpression in prostate cancer cells.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic and functional effects of DDC and SLC6A4 overexpression in prostate cancer cells.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table Oligonucleotides
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table Oligonucleotides
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Data from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC.Significance:Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC.Significance:Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonin-associated genes and pathways are enriched in NEPC.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonin-associated genes and pathways are enriched in NEPC.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
AR blockade induces DDC upregulation and serotonin-dependent neuroendocrine lineage reprogramming.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
AR blockade induces DDC upregulation and serotonin-dependent neuroendocrine lineage reprogramming.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table. List of antibodies and small molecules used in this project
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table. List of antibodies and small molecules used in this project
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic stratification of prostate cancer patient cohorts reveals serotonin-axis activation in NE⁺ tumors.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic stratification of prostate cancer patient cohorts reveals serotonin-axis activation in NE⁺ tumors.